Cellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Update

Cellebrite DI Ltd. (NASDAQ:CLBT) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,170,000 shares, a growth of 13.6% from the December 15th total of 1,030,000 shares. Based on an average daily volume of 1,310,000 shares, the short-interest ratio is currently 0.9 days. Approximately 1.4% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Craig Hallum raised their price objective on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Needham & Company LLC lifted their target price on shares of Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. lifted their target price on shares of Cellebrite DI from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Monday, December 16th. Finally, TD Cowen lifted their target price on shares of Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Monday, September 23rd. Eight investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Cellebrite DI has an average rating of “Buy” and a consensus target price of $20.57.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CLBT. Renaissance Technologies LLC increased its holdings in shares of Cellebrite DI by 22.1% during the 2nd quarter. Renaissance Technologies LLC now owns 1,183,700 shares of the company’s stock worth $14,145,000 after purchasing an additional 214,600 shares during the period. Hsbc Holdings PLC increased its holdings in shares of Cellebrite DI by 44.7% during the 2nd quarter. Hsbc Holdings PLC now owns 238,002 shares of the company’s stock worth $2,866,000 after purchasing an additional 73,533 shares during the period. Public Employees Retirement Association of Colorado bought a new position in shares of Cellebrite DI during the 2nd quarter worth about $71,000. Sei Investments Co. increased its stake in Cellebrite DI by 16.9% in the second quarter. Sei Investments Co. now owns 141,644 shares of the company’s stock valued at $1,693,000 after acquiring an additional 20,478 shares during the period. Finally, Magnetar Financial LLC bought a new stake in shares of Cellebrite DI in the 2nd quarter valued at approximately $143,000. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Price Performance

Shares of CLBT opened at $22.78 on Friday. The company has a market capitalization of $4.69 billion, a PE ratio of -14.70, a price-to-earnings-growth ratio of 3.18 and a beta of 1.46. Cellebrite DI has a one year low of $8.23 and a one year high of $23.50. The company’s fifty day moving average price is $20.76 and its 200 day moving average price is $17.56.

Cellebrite DI (NASDAQ:CLBT) last announced its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. The firm had revenue of $106.90 million for the quarter, compared to the consensus estimate of $102.06 million. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business’s quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.09 EPS. Analysts anticipate that Cellebrite DI will post 0.32 earnings per share for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.